-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on DexCom, Raises Price Target to $93

Benzinga·07/31/2026 13:10:40
Listen to the news
Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $87 to $93.